HAWKINS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.2 USD | +0.32% |
|
+3.29% | +9.63% |
| Apr. 17 | ReNeuron Group Reports CFO Resignation | MT |
| Apr. 17 | ReNeuron CFO steps down to pursue other opportunities | AN |
Financials (USD)
| Sales 2024 * | 914M | Sales 2025 * | 984M | Capitalization | 1.61B |
|---|---|---|---|---|---|
| Net income 2024 * | 74M | Net income 2025 * | 77M | EV / Sales 2024 * | 1.76 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.64 x |
| P/E ratio 2024 * |
21.3
x | P/E ratio 2025 * |
21
x | Employees | 849 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.85% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +1.30% | ||
| 1 week | +1.16% | ||
| Current month | +0.20% | ||
| 1 month | +0.09% | ||
| 3 months | +14.32% | ||
| 6 months | +37.41% | ||
| Current year | +9.27% |
1 week
74.30
77.16
1 month
72.8679.30
Current year
54.4479.30
1 year
39.2079.30
3 years
29.9379.30
5 years
13.4179.30
10 years
13.4179.30
| Managers | Title | Age | Since |
|---|---|---|---|
Patrick Hawkins
CEO | Chief Executive Officer | 53 | 91-12-31 |
| Director of Finance/CFO | 51 | 17-04-30 | |
Drew Grahek
COO | Chief Operating Officer | 54 | 18-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Thompson
CHM | Chairman | 73 | 08-12-31 |
Mary Schumacher
BRD | Director/Board Member | 67 | 11-12-31 |
Jeffrey Wright
BRD | Director/Board Member | 61 | 08-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.65% | 4 M€ | -5.15% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 77.2 | +0.32% | 64 871 |
| 24-04-23 | 76.95 | +1.30% | 66,331 |
| 24-04-22 | 75.96 | +1.78% | 74,441 |
| 24-04-19 | 74.63 | -0.09% | 357,503 |
| 24-04-18 | 74.7 | -0.05% | 115,749 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotes
Hawkins, Inc. is a specialty chemical and ingredients company that formulates, distributes, blends and manufactures products for its customers. The Company operates through three segments: Industrial, Water Treatment, and Health and Nutrition. Its Industrial segment specializes in providing industrial chemicals, products and services to industries such as agriculture, chemical processing, electronics, energy, food, pharmaceutical and plating. The Water Treatment segment specializes in providing chemicals, equipment and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water and agricultural water. The Health and Nutrition segment specializes in providing ingredient distribution, processing and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, health and wellness products.
Sector
Diversified Chemicals
Calendar
2024-05-14
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
76.95
USD
Average target price
74
USD
Spread / Average Target
-3.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +9.27% | 1.61B | |
| +5.49% | 48.78B | |
| -4.06% | 30.85B | |
| +8.38% | 17.8B | |
| -9.04% | 11.66B | |
| +7.77% | 11.38B | |
| +3.37% | 9.84B | |
| -7.87% | 9.83B | |
| +6.01% | 9.31B | |
| +5.28% | 8.35B |
- Stock Market
- Equities
- HWKN Stock
